Evidence of altered age-related brain cytoarchitecture in mouse models of down syndrome: A diffusional kurtosis imaging study

Magnetic Resonance Imaging

Volumn 33, Issue 4, 2015, Pages 437-447

  Nie, Xingju ^a   Hamlett, Eric D ^a   Granholm, Ann Charlotte ^a   Hui, Edward S ^b   Helpern, Joseph A ^a   Jensen, Jens H ^a   Boger, Heather A ^a   Collins, Heather R ^a   Falangola, Maria F ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Diffusion; DKI; Down syndrome; Kurtosis; Mouse; MRI

Indexed keywords

AGE; AGE DISTRIBUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN; CONTROLLED STUDY; CORPUS STRIATUM; CYTOARCHITECTURE; DEVELOPMENTAL DISORDER; DEVELOPMENTAL STAGE; DIFFUSIONAL KURTOSIS IMAGING; DOWN SYNDROME; FRONTAL CORTEX; HIPPOCAMPUS; MALE; MOUSE; NERVE DEGENERATION; NEUROPATHOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; AGING; ALGORITHM; ANIMAL; C3H MOUSE; C57BL MOUSE; COMPUTER ASSISTED DIAGNOSIS; DIFFUSION WEIGHTED IMAGING; IMAGE ENHANCEMENT; PATHOLOGY; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; TRANSGENIC MOUSE;

MUS;

AGING; ALGORITHMS; ANIMALS; BRAIN; DIFFUSION MAGNETIC RESONANCE IMAGING; DOWN SYNDROME; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, TRANSGENIC; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84927911157     PISSN: 0730725X     EISSN: 18735894     Source Type: Journal    
DOI: 10.1016/j.mri.2014.12.008     Document Type: Article

References (70)

1. Tyrrell J., Cosgrave M., McCarron M., McPherson J., Calvert J., Kelly A., et al. Dementia in people with Down's syndrome. Int J Geriatr Psychiatry 2001, 16(12):1168-1174.
2. Lott I.T., Head E. Down syndrome and Alzheimer's disease: a link between development and aging. Ment Retard Dev Disabil Res Rev 2001, 7(3):172-178.
3. Albert M.S. Parallels between Down syndrome dementia and Alzheimer's disease. Prog Clin Biol Res 1992, 379:77-102.
4. Bakkar Rania M., Luo Guangju, Webb Thomas A., Crutcher Keith A., de Courten-Myers Gabrielle M. Down's syndrome with Alzheimer's disease-like pathology: what can it teach us about the amyloid cascade hypothesis?. Int J Alzheimers Dis 2010, 2010. [Article ID 175818]. 10.4061/2010/175818.
5. Davisson M.T., Schmidt C., Reeves R.H., Irving N.G., Akeson E.C., Harris B.S., et al. Segmental trisomy as a mouse model for Down syndrome. Prog Clin Biol Res 1993, 384:117-133.
6. Reeves R.H., Irving N.G., Moran T.H., Wohn A., Kitt C., Sisodia S.S., et al. A mouse model for Down syndrome exhibits learning and behavior deficits. Nat Genet 1995, 11:177-184.
7. Sérégaza Z., Roubertoux P.L., Jamon M., Soumireu-Mourat B. Mouse models of cognitive disorders in trisomy 21: a review. Behav Genet 2006, 36(3):387-404.
8. Roubertoux P.L., Carlier M. Mouse models of cognitive disabilities in trisomy 21 (Down syndrome). Am J Med Genet C: Semin Med Genet 2010, 154C(4):400-416. [Review].
9. Das I., Reeves R.H. The use of mouse models to understand and improve cognitive deficits in Down syndrome. Dis Model Mech 2011, 4:596-606.
10. Liu C., Belichenko P.V., Zhang L., Fu D., Kleschevnikov A.M., Baldini A., et al. Mouse models for Down syndrome-associated developmental cognitive disabilities. Dev Neurosci 2011, 33(5):404-413.
11. Holtzman D.M., Santucci D., Kilbridge J., Chua-Couzens J., Fontana D.J., Daniels S.E., et al. Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome. Proc Natl Acad Sci U S A 1996, 93(23):13333-13338.
12. Villar A.J., Belichenko P.V., Gillespie A.M., Kozy H.M., Mobley W.C., Epstein C.J. Identification and characterization of a new Down syndrome model, Ts[Rb(12.1716)]2Cje, resulting from a spontaneous Robertsonian fusion between T(171)65Dn and mouse chromosome 12. Mamm Genome 2005, 16(2):79-90.
13. Hyde L.A., Crnic L.S. Age-related deficits in context discrimination learning in Ts65Dn mice that model Down syndrome and Alzheimer's disease. Behav Neurosci 2001, 115(6):1239-1246.
14. Lockrow J.P., Fortress A.M., Granholm A.C. Age-related neurodegeneration and memory loss in down syndrome. Curr Gerontol Geriatr Res 2012, 2012:463909. 10.1155/2012/463909.
15. Gotti S., Caricati E., Panzica G. Alterations of brain circuits in Down syndrome murine models. J Chem Neuroanat 2011, 42(4):317-326.
16. Seo H., Isacson O. Abnormal APP, cholinergic and cognitive function in Ts65Dn Down's model mice. Exp Neurol 2005, 193(2):469-480.
17. Lockrow J., Prakasam A., Huang P., Bimonte-Nelson H., Sambamurti K., Granholm A.C. Cholinergic degeneration and memory loss delayed by vitamin E in a Down syndrome mouse model. Exp Neurol 2009, 216:278-289.
18. Siarey R.J., Stoll J., Rapoport S.I., Galdzicki Z. Altered long-term potentiation in the young and old Ts65Dn mouse, a model for Down Syndrome. Neuropharmacology 1997, 36(11-12):1549-1554.
19. Costa A.C., Grybko M.J. Deficits in hippocampal CA1 LTP induced by TBS but not HFS in the Ts65Dn mouse: a model of Down syndrome. Neurosci Lett 2005, 382:317-322.
20. Dierssen M., Benavides-Piccione R., Martínez-Cué C., Estivill X., Florez J., Elston G.N., et al. Alterations of neocortical pyramidal cell pheno-type in theTs65Dn mouse model of Down syndrome:effects of environmental enrichment. Cereb Cortex 2003, 13:758-764.
21. Belichenko P.V., Masliah E., Kleschevnikov A.M., Villar A.J., Epstein C.J., Salehi A., et al. Synaptic structural abnormalities in the Ts65Dn mouse model of Down Syndrome. J Comp Neurol 2004, 480(3):281-298.
22. Belichenko P.V., Kleschevnikov A.M., Salehi A., Epstein C.J., Mobley W.C. Synaptic and cognitive abnormalities in mouse models of Down syndrome: exploring genotype-phenotype relationships. J Comp Neurol 2007, 504(4):329-345.
23. Popov V.I., Kleschevnikov A.M., Klimenko O.A., Stewart M.G., Belichenko P.V. Three-dimensional synaptic ultrastructure in the dentate gyrus and hippocampal area CA3 in the Ts65Dn mouse model of Down syndrome. J Comp Neurol 2011, 519(7):1338-1354.
24. Benavides-Piccione R., Ballesteros-Yáñez I., de Lagrán M.M., Elston G., Estivill X., Fillat C., et al. On dendrites in Down syndrome and DS murine models: a spiny way to learn. Prog Neurobiol 2004, 74(2):111-126. [Review].
25. Escorihuela R.M., Vallina I.F., Martínez-Cué C., Baamonde C., Dierssen M., Tobeña A., et al. Impaired short- and long-term memory in Ts65Dn mice, a model for Down syndrome. Neurosci Lett 1998, 247(2-3):171-174.
26. Hunter C.L., Bimonte H.A., Granholm A.C. Behavioral comparison of 4 and 6month-old Ts65Dn mice: age-related impairments in working and reference memory. Behav Brain Res 2003, 138(2):121-131.
27. Granholm A.C., Sanders L.A., Crnic L.S. Loss of cholinergic phenotype in basal forebrain coincides with cognitive decline in a mouse model of Down's syndrome. Exp Neurol 2000, 161(2):647-663.
28. Bimonte-Nelson H.A., Hunter C.L., Nelson M.E., Granholm A.C. Frontal cortex BDNF levels correlate with working memory in an animal model of Down syndrome. Behav Brain Res 2003, 139(1-2):47-57.
29. Wilcock D.M., Griffin W.S. Down's syndrome, neuroinflammation, and Alzheimer neuropathogenesis. J Neuroinflammation 2013, 10:84. 10.1186/1742-2094-10-84.
30. Chen Y., Dyakin V.V., Branch C.A., Ardekani B., Yang D., Guilfoyle D.N., et al. In vivo MRI identifies cholinergic circuitry deficits in a Down syndrome model. Neurobiol Aging 2009, 30(9):1453-1465.
31. Ishihara K., Amano K., Takaki E., Shimohata A., Sago H., Epstein C.J., et al. Enlarged brain ventricles and impaired neurogenesis in the Ts1Cje and Ts2Cje mouse models of Down syndrome. Cereb Cortex 2010, 20(5):1131-1143.
32. Kaur G., Sharma A., Xu W., Gerum S., Alldred M.J., Subbanna S., et al. Glutamatergic transmission aberration: a major cause of behavioral deficits in a murine model of Down's syndrome. J Neurosci 2014, 34(15):5099-5106.
33. Santin M.D., Valabrègue R., Rivals I., Pénager R., Paquin R., Dauphinot L., et al. In vivo (1) H MRS study in microlitre voxels in the hippocampus of a mouse model of Down syndrome at 11.7T. NMR Biomed 2014, [[Epub ahead of print] PubMed PMID: 25088227]. 10.1002/nbm.3155.
34. Abe O., Aoki S., Hayashi N., Yamada H., Kunimatsu A., Mori H., et al. Normal aging in the central nervous system: quantitative MR diffusion-tensor analysis. Neurobiol Aging 2002, 23(3):433-441. [PMID: 11959406].
35. Stebbins G.T., Murphy C.M. Diffusion tensor imaging in Alzheimer's disease and mild cognitive impairment. Behav Neurol 2009, 21(1):39-49. [Review. PMCID: PMC3010401].
36. Jensen J.H., Helpern J.A., Ramani A., Lu H., Kaczynski K. Diffusional kurtosis imaging: the quantification of non-Gaussian water diffusion by means of MRI. Magn Reson Med 2005, 53:1432-1440.
37. Lu H., Jensen J.H., Ramani A., Helpern J.A. Three-dimensional characterization of non-Gaussian water diffusion in humans using diffusion kurtosis imaging. NMR Biomed 2006, 19(2):236-247.
38. Jensen J.H., Helpern J.A. MRI quantification of non-Gaussian water diffusion by kurtosis analysis. NMR Biomed 2010, 23(7):698-710.
39. Falangola M.F., Jensen J.H., Babb J.S., Hu C., Castellanos F.X., Di Martino A., et al. Age-related non-Gaussian diffusion patterns in the prefrontal brain. J Magn Reson Imaging 2008, 28(6):1345-1350.
40. Helpern J.A., Adisetiyo V., Falangola M.F., Hu C., Di Martino A., Williams K., et al. Preliminary evidence of altered gray and white matter microstructural development in the frontal lobe of adolescents with attention-deficit hyperactivity disorder: a diffusional kurtosis imaging study. J Magn Reson Imaging 2011, 33(1):17-23.
41. Jensen J.H., Falangola M.F., Hu C., Tabesh A., Rapalino O., Lo C., et al. Preliminary observations of increased diffusional kurtosis in human brain following recent cerebral infarction. NMR Biomed 2011, 24(5):452-457.
42. Hui E.S., Fieremans E., Jensen J.H., Tabesh A., Feng W., Bonilha L., et al. Stroke assessment with diffusional kurtosis imaging. Stroke 2012, 43(11):2968-2973.
43. Van Cauter S., Veraart J., Sijbers J., Peeters R.R., Himmelreich U., De Keyzer F., et al. Gliomas: diffusion kurtosis MR imaging in grading. Radiology 2012, 263(2):492-501.
44. Grossman E.J., Ge Y., Jensen J.H., Babb J.S., Miles L., Reaume J., et al. Thalamus and cognitive impairment in mild traumatic brain injury: a diffusional kurtosis imaging study. J Neurotrauma 2011, 29(13):2318-2327.
45. Falangola M.F., Jensen J.H., Tabesh A., Hu C., Deardorff R.L., Babb J.S., et al. Non-Gaussian diffusion MRI assessment of brain microstructure in mild cognitive impairment and Alzheimer's disease. Magn Reson Imaging 2013, 31(6):840-846.
46. Coutu J.P., Chen J.J., Rosas H.D., Salat D.H. Non-Gaussian water diffusion in aging white matter. Neurobiol Aging 2014, 35(6):1412-1421.
47. Gong N.J., Wong C.S., Chan C.C., Leung L.M., Chu Y.C. Aging in deep gray matter and white matter revealed by diffusional kurtosis imaging. Neurobiol Aging 2014, 35(10):2203-2216.
48. Cheung M.M., Hui E.S., Chan K.C., Helpern J.A., Qi L., Wu E.X. Does diffusion kurtosis imaging lead to better neural tissue characterization? A rodent brain maturation study. Neuroimage 2009, 45(2):386-392. [PMID: 19150655].
49. Falangola M.F., Guilfoyle D., Hui E.S., Hu C., Gerum S., LaFrancois J., et al. Diffusional kurtosis imaging detects age-related grey matter changes in the normal mouse brain. Proc Intl Soc Mag Reson Med 2012, 20:1241.
50. Vanhoutte G., Pereson S., Delgado Y., Palacios R., Guns P.J., Asselbergh B., et al. Diffusion kurtosis imaging to detect amyloidosis in an APP/PS1 mouse model for Alzheimer's disease. Magn Reson Med 2013, 69(4):1115-1121.
51. Falangola M.F., Guilfoyle D.N., Tabesh A., Hui E.S., Nie X., Jensen J.H., et al. Histological correlation of diffusional kurtosis and white matter modeling metrics in cuprizone-induced corpus callosum demyelination. NMR Biomed 2014, [[Epub ahead of print] PubMed PMID: 24890981]. 10.1002/nbm.3140.
52. Davisson M.T., Schmidt C., Akeson E.C. Segmental trisomy of murine chromosome 16: a new model system for studying Down syndrome. Prog Clin Biol Res 1990, 360:263-280.
53. Tabesh A., Jensen J.H., Ardekani B.A., Helpern J.A. Estimation of tensors and tensor-derived measures in diffusional kurtosis imaging. Magn Reson Med 2011, 65(3):823-836.
54. Veraart J., Poot D.H.J., Van Hecke W., et al. More accurate estimation of diffusion tensor parameters using diffusion kurtosis imaging. Magn Reson Med 2011, 65(1):138-145.
55. Paxinos G., Franklin K. The mouse brain in stereotaxic coordinates: compact (Academic, San Diego) 2003, 2nd ed.
56. Cohen J., Cohen P., West S.G., Aiken L.S. Applied multiple regression/correlation analysis for the behavioral sciences 2003, Lawrence, Mahwah, NJ. 3rd ed.
57. Soper D.S. Significance of the difference between two slopes calculator [software] Available from. http://www.danielsoper.com/statcalc.
58. Aldridge K., Reeves R.H., Olson L.E., Richtsmeier J.T. Differential effects of trisomy on brain shape and volume in related aneuploid mouse models. Am J Med Genet A 2007, 143A(10):1060-1070.
59. Fillat C., Dierssen M., de Lagrán M.M., Altafaj X. Insights from mouse models to understand neurodegeneration in Down syndrome. CNS Neurol Disord Drug Targets 2010, 9(4):429-438. [Review].
60. Goffinet Andre M., Rakic Pasko Mouse brain development 2000, Springer, Berlin Heidelberg.
61. Hedley-Whyte E.T., Kirschner D.A. Morphological evidence of alteration in myelinstructure with maturation. Brain Res 1976, 113(3):487-497.
62. deToledo-Morrell L., Geinisman Y., Morrell F. Age-dependent alterations in hippocampal synaptic plasticity: relation to memory disorders. Neurobiol Aging 1988, 9(5-6):581-590. [Review].
63. Haydar T.F., Reeves R.H. Trisomy 21 and early brain development. Trends Neurosci 2012, 35(2):81-91. [Review].
64. Ábrahám H., Vincze A., Veszprémi B., Kravják A., Gömöri É., Kovács G.G., et al. Impaired myelination of the human hippocampal formation in Down syndrome. Int J Dev Neurosci 2012, 30(2):147-158.
65. Di Filippo M., Tozzi A., Ghiglieri V., Picconi B., Costa C., Cipriani S., et al. Impaired plasticity at specific subset of striatal synapses in the Ts65Dn mouse model of Down syndrome. Biol Psychiatry 2010, 67(7):666-671.
66. Wisniewski K.E., Schmidt-Sidor B. Postnatal delay of myelin formation in brains from Down syndrome infants and children. Clin Neuropathol 1989, 8(2):55-62.
67. Meitzner M.C., Skurnowicz J.A. Anesthetic considerations for patients with Down syndrome. AANA J 2005, 73(2):103-107. [Review].
68. Tang J.X., Eckenhoff M.F. Anesthetic effects in Alzheimer transgenic mouse models. Prog Neuropsychopharmacol Biol Psychiatry 2013, 47:167-171.
69. Menuet C., Borghgraef P., Voituron N., Gestreau C., Gielis L., Devijver H., et al. Isoflurane anesthesia precipitates tauopathy and upper airways dysfunction in pre-symptomatic Tau.P301L mice: possible implication for neurodegenerative diseases. Neurobiol Dis 2012, 46(1):234-243.
70. Hui E.S., Russell Glenn G., Helpern J.A., Jensen J.H. Kurtosis analysis of neural diffusion organization. Neuroimage 2015, 106:391-403. 10.1016/j.neuroimage.2014.11.015.